TGStat
TGStat
Type to search
Advanced channel search
English
Site language
Russian
English
Uzbek
Sign In
Catalog
Channels and groups catalog
Search for channels
Add a channel/group
Ratings
Rating of channels
Rating of groups
Posts rating
Ratings of brands and people
Analytics
Search by posts
Telegram monitoring
묻따방
7 Nov 2020, 05:15
Open in Telegram
Share
Report
Forward from:
한투증권 제약바이오 진홍국
FDA 자문위, 아두카누맙 승인 불허 권고
https://www.cnbc.com/2020/11/06/biogen-suffers-setback-after-alzheimers-drug-fails-to-win-support-from-fda-panel-.html
Biogen hits snag after Alzheimer's drug fails to win support from FDA panel
If fully approved, it would be the first drug to slow cognitive decline in people living with the disease and the first new treatment for Alzheimer's in nearly 20 years.
1.4k
0
0
×
